294 related articles for article (PubMed ID: 36284668)
21. LncRNA MALAT1 inhibits apoptosis of endometrial stromal cells through miR-126-5p-CREB1 axis by activating PI3K-AKT pathway.
Feng Y; Tan BZ
Mol Cell Biochem; 2020 Dec; 475(1-2):185-194. PubMed ID: 32809092
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis.
Zhao H; Wan J; Zhu Y
Drug Des Devel Ther; 2020; 14():3417-3427. PubMed ID: 32904674
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating microRNA-191-5p/brain derived neurotrophic factor.
Xu Y; Fu Z; Gao X; Wang R; Li Q
Bioengineered; 2021 Dec; 12(1):1587-1598. PubMed ID: 33942699
[TBL] [Abstract][Full Text] [Related]
24. Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway.
Liu Y; Liang G; Zhou T; Liu Z
Pathol Oncol Res; 2020 Apr; 26(2):1079-1088. PubMed ID: 31044388
[TBL] [Abstract][Full Text] [Related]
25. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
[TBL] [Abstract][Full Text] [Related]
26. Long intergenic non-protein coding RNA 115 (LINC00115) aggravates retinoblastoma progression by targeting microRNA miR-489-3p that downregulates 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (PFKFB2).
Ji F; Dai C; Xin M; Zhang J; Zhang Y; Liu S
Bioengineered; 2022 Mar; 13(3):5330-5343. PubMed ID: 35184643
[TBL] [Abstract][Full Text] [Related]
27. Long Non-coding RNA MALAT1 Alleviates the Elevated Intraocular Pressure (Eiop)-induced Glaucoma Progression via Sponging miR-149-5p.
Wang L; Gong J; Wang J; Dan J; Wang P
Curr Eye Res; 2021 Jun; 46(6):903-911. PubMed ID: 33108931
[No Abstract] [Full Text] [Related]
28. MicroRNA‑382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF‑mediated PI3K/AKT signalling pathway.
Song D; Diao J; Yang Y; Chen Y
Mol Med Rep; 2017 Nov; 16(5):6428-6436. PubMed ID: 28901408
[TBL] [Abstract][Full Text] [Related]
29. Panax notoginseng saponins induce apoptosis in retinoblastoma Y79 cells via the PI3K/AKT signalling pathway.
Liu J; Zhang C; Jia B; Dong K; Li M; Qiu D; Li L; Xu B; Sun S; Li C
Exp Eye Res; 2022 Mar; 216():108954. PubMed ID: 35074343
[TBL] [Abstract][Full Text] [Related]
30. AFAP1 antisense RNA 1 promotes retinoblastoma progression by sponging microRNA miR-545-3p that targets G protein subunit beta 1.
Tang W; Zhang L; Li J; Guan Y
Bioengineered; 2022 Mar; 13(3):5638-5652. PubMed ID: 35193469
[TBL] [Abstract][Full Text] [Related]
31. Circ_0000527 Drives Retinoblastoma Progression by Regulating miR-1236-3p/SMAD2 Pathway.
Liang T; Fan M; Meng Z; Sun B; Mi S; Gao X
Curr Eye Res; 2022 Apr; 47(4):624-633. PubMed ID: 34963405
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
33. MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway.
Gui F; Hong Z; You Z; Wu H; Zhang Y
Cell Biol Int; 2016 Dec; 40(12):1294-1302. PubMed ID: 27600360
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA XIST confers aggressive progression via miR-361-3p/STX17 in retinoblastoma cells.
Yang LL; Li Q; Zhang X; Cao T
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10433-10444. PubMed ID: 33155266
[TBL] [Abstract][Full Text] [Related]
35. LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.
Wu HY; Wang XH; Liu K; Zhang JL
Cell Cycle; 2020 Jan; 19(1):39-52. PubMed ID: 31774373
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
Song L; Huang Y; Zhang X; Han S; Hou M; Li H
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway.
Liu F; Zhang Q; Liang Y
J Cell Biochem; 2020 Mar; 121(3):2294-2302. PubMed ID: 31674056
[TBL] [Abstract][Full Text] [Related]
38. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
39. LncRNA MALAT1 mediates proliferation of LPS treated-articular chondrocytes by targeting the miR-146a-PI3K/Akt/mTOR axis.
Li H; Xie S; Li H; Zhang R; Zhang H
Life Sci; 2020 Aug; 254():116801. PubMed ID: 31472145
[TBL] [Abstract][Full Text] [Related]
40. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
